These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3520999

  • 21. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME, Marsden JT, Reid KE, Bewick M, Holt DW.
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract] [Full Text] [Related]

  • 22. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs.
    Yamauchi J, Akiyama N, Sugimoto H, Tomikawa S, Mita K, Bekku Y, Ogawa Y, Imai T.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545
    [No Abstract] [Full Text] [Related]

  • 23. Maintenance immunosuppression without steroids in pediatric liver transplantation.
    Margarit C, Martínez Ibañez V, Tormo R, Infante D, Iglesias H.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2230-1. PubMed ID: 2652721
    [No Abstract] [Full Text] [Related]

  • 24. Synergistic effects of cyclosporine and steroid therapy in the induction of specific unresponsiveness to DLA-identical canine renal allografts.
    Hayashi R, Meek AG, Arnold AN, Sonoda K, Ishimaru M, Strober S, Rapaport FT.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):391-2. PubMed ID: 2650157
    [No Abstract] [Full Text] [Related]

  • 25. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD, Flemming C.
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [Abstract] [Full Text] [Related]

  • 26. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
    Takahashi K, Yagisawa T, Tanabe I, Teraoka S, Hayasaka Y, Yasuo M, Fuchinoue S, Honda H, Toma H, Agishi T.
    Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
    [No Abstract] [Full Text] [Related]

  • 27. [After care of kidney transplant patients].
    Castro LA, Eigler J, Land W.
    Internist (Berl); 1983 Sep; 24(9):510-6. PubMed ID: 6313541
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of acute rejection with cyclosporine.
    Pettersson E, Ahonen J, Eklund B, Höckerstedt K, Salmela K, von Willebrand E, Häyry P.
    Transplant Proc; 1984 Oct; 16(5):1205-7. PubMed ID: 6385379
    [No Abstract] [Full Text] [Related]

  • 31. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fractional excretion of sodium during pulses of methylprednisolone for treatment of acute rejection in heart and kidney transplants.
    Lloveras JJ, Tran Van T, Magues JP, Bernadet P, Durand D, Suc JM.
    Transplant Proc; 1990 Aug; 22(4):1384-5. PubMed ID: 2389337
    [No Abstract] [Full Text] [Related]

  • 34. Contribution of acute rejection to renal allograft loss from chronic rejection.
    Sumrani N, Cacciarelli TV, Georgi B, Daskalakis P, Miles AM, Goldberg K, Hong JH, Sommer BG.
    Transplant Proc; 1993 Jun; 25(3):2259-60. PubMed ID: 8516892
    [No Abstract] [Full Text] [Related]

  • 35. Renal transplantation at the University of Wisconsin in the cyclosporine era.
    Knechtle SJ, Pirsch JD, D'Alessandro AM, Sollinger HW, Kalayoglu M, Belzer FO.
    Clin Transpl; 1993 Jun; ():211-8. PubMed ID: 7918154
    [Abstract] [Full Text] [Related]

  • 36. [Present status and perspectives of kidney transplantation].
    May G.
    Z Gesamte Inn Med; 1986 May 15; 41(10):294-7. PubMed ID: 3529663
    [Abstract] [Full Text] [Related]

  • 37. Lymphokine production in cyclosporine-treated renal transplant recipients.
    McKenna RM, Rush DN, Bakkestad-Legare P, Jeffrey JR.
    Transplant Proc; 1988 Dec 15; 20(6):1245-7. PubMed ID: 3144073
    [No Abstract] [Full Text] [Related]

  • 38. Heterotopic versus orthotopic heart transplantation.
    Barnard CN, Cooper DK.
    Transplant Proc; 1984 Jun 15; 16(3):886-92. PubMed ID: 6375048
    [No Abstract] [Full Text] [Related]

  • 39. ALG treatment of steroid-resistant rejection in patients receiving cyclosporine.
    Matas AJ, Tellis VA, Quinn T, Glichlick D, Soberman R, Weiss R, Karwa G, Veith FJ.
    Transplantation; 1986 May 15; 41(5):579-83. PubMed ID: 3518163
    [Abstract] [Full Text] [Related]

  • 40. Improved results using pediatric cadaver donor kidneys with cyclosporine immunosuppression.
    Hayes JM, Novick AC, Steinmuller DR, Streem SB, Hodge EE, Bretan PN, Cunningham R, Graneto D.
    Transplant Proc; 1988 Jun 15; 20(3 Suppl 3):209-14. PubMed ID: 3291245
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.